I n 2017, a 14-year-old boy from Côte d'Ivoire who had crossed the Sahara Desert through Niger and reached Europe by sea from Libya was referred to the Consultation Board at the Parasitology Unit of Angers University Hospital (Angers, France) for painless gross hematuria. Aside from hematuria, his physical examination was unremarkable. Blood tests revealed microcytic anemia (hemoglobin 103 g/L, mean corpuscular volume 57.1 fL, mean corpuscular hemoglobin concentration 285 g/L) and a low serum ferritin level (8 µg/L). Leukocyte and eosinophil counts and biochemical markers of liver and kidney function were within reference limits. Serologic test results were negative for antibodies to HIV, hepatitis B and C virus, and Treponema pallidum. Serodiagnostic test results were negative for cystic and alveolar echinococcoses and strongyloidiasis, and schistosomiasis screening test results were inconclusive: positive by Schistosoma mansoni-specific ELISA (optical density 1.02, threshold 0.53; Bordier Affinity Products, http://www.bordier.ch/) and negative by S. mansoni indirect hemagglutination test (titer 1:40, threshold 1:160; Bilharziosis Fumouze; https://www.biosynex.com/).
To clarify diagnosis, we performed the SCHISTO II Western Blot IgG (LDBio Diagnostics, http://www. ldbiodiagnostics.com/), which showed 5 unequivocal bands, including a large band at 22-24 kDa and 30-34 kDa, results indicative of schistosomiasis. We corroborated our results by microscopic examination of patient feces and urine. We detected lateral-spined eggs (typical of S. mansoni parasites) in a fecal specimen processed by using the Kato-Katz method and, surprisingly, lateral-spined eggs and terminal-spined eggs (typical of Schistosoma haematobium parasites) in a 24-hour urine specimen filtered through a 12-micron membrane (Figure, panel  A) . The patient received a single 40 mg/kg dose of praziquantel. The patient experienced no more episodes of hematuria for the following 6 months; however, we could not assess his parasitological responses.
We genotyped both terminal-and lateral-spined eggs individually using a previously described protocol (1). All terminal-spined eggs were characterized by mitochondrial cox1 genes (GenBank accession nos. MG562514-5) and the nuclear internal transcribed spacer (ITS) (GenBank accession no. MG554667) specific to S. haematobium schistosomes. All chromatograms of ITS genes from lateral-spined eggs showed a double profile: 1 identical to S. mansoni schistosomes (GenBank accession no. MG554659) and 1 identical to S. haematobium (GenBank accession no. MG554667). Moreover, the cox1 haplotypes of these eggs were either specific to S. haematobium (GenBank accession no. MG562514) or S. mansoni (GenBank accession nos. MG562512-3) parasites. The phylogenetic tree of S. mansoni cox1 sequences indicates that the parasite responsible for this infection originated from Far West Africa; the hybrid parasite's haplotypes clustered with those of schistosomes from Niger, Senegal, and Mali ( Figure, panel B) .
Schistosomiasis represents a serious disease burden worldwide and is ranked the 12th most common travel-associated infection in Europe (2). The migration crisis has led to a large flow of persons (notably children) from West Africa. Unaccompanied foreign minors are protected under the 1989 United Nations Convention on the Rights of the Child (https:// www.ohchr.org/en/professionalinterest/pages/crc.aspx). Moreover, because of the high prevalence of schistosomiasis in their countries of origin, these children receive care for this disease upon their arrival in Maine-et-Loire Department (Loire Valley, France). This preventive strategy enabled us to diagnose schistosomiasis in ≈25% of travelers and migrants (Y. Le Govic, unpub. data), a result in accordance with a similar screening program in Italy (3). This strategy also enabled us to detect the case of mixed Schistosoma parasite infection with ectopic egg elimination described in this report.
Ectopic egg elimination (i.e., S. haematobium schistosome eggs in feces and S. mansoni eggs in urine) frequently occurs in endemic areas; in a study in northern Senegal, 53% of patients infected with Schistosoma parasites had simultaneous infections with S. mansoni and S. haematobium parasites, of which 15% displayed ectopic egg elimination (4). This phenomenon can occur because of parasite hybridization. Hybrids resulting from S. mansoni and S. haematobium schistosome cross-breeding have been documented in northern Senegal (5). The fact that the patient we describe never traveled through Senegal strongly suggests that such hybrids are more widespread than previously observed.
Hybrid schistosomes are particularly worrisome. The outbreak in Corsica Island involved infections with S. haematobium-Schistosoma bovis hybrid parasites (1,6), which might be more difficult to diagnose (7) . Experimental studies have revealed that interspecific hybridization might enhance infectivity, virulence, and longevity and accelerate cercarial maturation. Also, hybrids can have wider host spectrums, potentially expanding their epidemiologic consequences (8) .
The risk for emergence of S. mansoni schistosome infection might exist in Europe; the Biomphalaria snail vector (namely B. tenagophila) has been detected for several years in Romania (9) . Given the nonnegligible prevalence of mansonic schistosomiasis in travelers and migrants entering Europe (3,10) and global warming, the probability of encounters between S. mansoni miracidia and their snail hosts might have increased. Moreover, whether S. mansoni-S. haematobium hybrid parasites are capable of infecting the Bulinus snail vector of the S. haematobium schistosome, which is widely distributed throughout Europe (France, Spain, Italy, Greece, Portugal) (11), remains unknown and deserves further investigation.
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To date, human disease caused by WNV has been attributed to WNV phylogenetic lineages 1 and 2 (3). Lineage 2 consists of viruses found in South Africa, Madagascar, and, more recently, in Europe and Russia (4). Lineage 2 was previously described as less pathogenic than lineage 1, but it has subsequently been demonstrated that lineage 2 can also lead to neuroinvasive disease (5). We describe a couple from the United Kingdom with confirmed WNV infection who were admitted to a hospital in February 2017 on return from a holiday to South Africa, where they most likely acquired WNV in the Kruger National Park region.
A previously healthy 76-year-old woman was admitted with acute confusion to Doncaster Royal Infirmary, Doncaster, UK. She and her husband had returned that day following a 3-week holiday visiting family in South Africa (Appendix Figure, http://wwwnc.cdc.gov/EID/article/25/2/17-2101-App1.pdf). The patient and her husband had stayed in Johannesburg, except for a 5-day safari in Kruger National Park 5 days into their trip. They had both sustained several mosquito and tick bites. No malaria prophylaxis had been taken, and no pretravel advice had been sought.
The patient boarded an airplane independently in Johannesburg but her condition deteriorated in flight; on arrival,
